導(dǎo)師簡(jiǎn)介

姓名：曹曉明性別：男政治面貌：中共黨員學(xué)歷：研究生學(xué)位：碩士職稱(chēng)：主任醫(yī)師

博、碩導(dǎo)師：博導(dǎo)，碩導(dǎo)本崗位工作年數(shù)：30年

研究方向：泌尿男生殖系腫瘤

榮譽(yù)稱(chēng)號(hào)：山西省臨床高端領(lǐng)軍人才，山西省學(xué)術(shù)技術(shù)帶頭人

學(xué)術(shù)任職：山西省醫(yī)學(xué)會(huì)泌尿外科學(xué)專(zhuān)業(yè)委員會(huì)主任委員

近五年承擔(dān)科研課題情況：

例如：一種基于PSMA-PET/CT新型前列腺癌淋巴結(jié)轉(zhuǎn)移預(yù)測(cè)模型的構(gòu)建（2020080）

代表性論著及近五年的代表性論文（限10項(xiàng)以?xún)?nèi)）：

1.Ma Z, Wang X, Zhang W, Gao K, Wang L, Qian L, Mu J, Zheng Z,Cao X*. Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI. World J Surg Oncol. 2023 Mar 7;21(1):83

2.Wu B, Shao Y, Lin X, Hasi C, Jia W, Wang D,Cao X*. Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study. Transl Androl Urol. 2023 Mar 31;12(3):425-432.

3.穆靖軍,馬增妮,曹曉明*.臨床局限性前列腺癌包膜外侵犯的危險(xiǎn)因素分析[J].中華腔鏡泌尿外科雜志（電子版）,2023,17(4):326-331.

4.Zhang W, Zhang W, Li X, Cao X, Yang G, Zhang H. Predicting Tumor Perineural Invasion Status in High-Grade Prostate Cancer Based on a Clinical-Radiomics Model Incorporating T2-Weighted and Diffusion-Weighted Magnetic Resonance Images. Cancers (Basel). 2022 Dec 23;15(1):86.

6.Shen P,Cao X, Sun L, Qian Y, Wu B, Wang X, Shi G, Wang D. KLF9 suppresses cell growth and induces apoptosis via the AR pathway in androgen-dependent prostate cancer cells. Biochem Biophys Rep. 2021 Oct 12;28:101151. doi: 10.1016/j.bbrep.2021.101151. PMID: 34703906; PMCID: PMC8521454.

7.Jia W, Wu B, Shao Y,Cao X, Wang D. Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy: A meta-analysis. Int J Urol. 2021 Mar;28(3):315-325. doi: 10.1111/iju.14464. Epub 2020 Dec 18. PMID: 33336418.

8.Xue R, Hu C, Zheng Z, Wei L, Yuan X, Lyu X, Shen P, Li J, Cao X* Renal?rotation techniques in retroperitoneoscopic adrenalectomy for giant pheochromocytomas: a clinical intervention study with historical controls. BMC Urol. 2023 Mar 29;23(1):47. doi: 10.1186/s12894-023-01221-w. PMID: 36991447; PMCID: PMC10061753.

8.任力娟,馬增妮,安淑靜,薛睿智,曹曉明*,雙衛(wèi)兵,茹峰.米拉貝隆聯(lián)合微生態(tài)制劑治療老年女性膀胱過(guò)度活動(dòng)癥患者探討[J].中華老年醫(yī)學(xué)雜志,2023,42(10):1223-1226.